Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Abeona Therapeutics Inc. (ABEO) had Income from Continuous Operations of $-5.16M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-5.16M |
|
$0.49M |
|
$-0.49M |
|
$24.02M |
|
$-24.02M |
|
$3.66M |
|
$-20.36M |
|
$-20.36M |
|
$-5.16M |
|
|
Income from Continuous Operations |
$-5.16M |
$-5.16M |
|
$-5.16M |
|
$-24.02M |
|
$-23.13M |
|
54.24M |
|
54.24M |
|
$-0.10 |
|
$-0.10 |
|
| Balance Sheet Financials | |
$216.13M |
|
$10.34M |
|
$14.96M |
|
$231.09M |
|
$22.18M |
|
$10.86M |
|
$37.68M |
|
$59.86M |
|
$171.23M |
|
$171.23M |
|
$171.23M |
|
52.40M |
|
| Cash Flow Statement Financials | |
$-58.37M |
|
$95.47M |
|
$22.43M |
|
$23.70M |
|
$83.22M |
|
$59.53M |
|
$8.22M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.74 |
|
-- |
|
-- |
|
0.06 |
|
0.12 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-65.19M |
|
-- |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
-- |
|
-- |
|
-3.01% |
|
-3.01% |
|
-2.23% |
|
-2.83% |
|
$3.27 |
|
$-1.20 |
|
$-1.08 |
|